Drugs / D-methionine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02903355 | Sep 2013 → Dec 2017 | noise induced hearing loss | Southern Illinois University | Terminated | Missed primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | D-methionine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02903355 ↗ |
| Known as | D-met | “This prospective study is a randomized, double-blind, placebo-controlled Phase 3 clinical trial of oral D-methionine (D-met) to reduce noise-induced hearing loss (NIHL) and tinnitus.” NCT02903355 ↗ |
| Route | Oral | “oral D-methionine” NCT02903355 ↗ |